Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Nanomedicine ; 47: 102612, 2023 01.
Artigo em Inglês | MEDLINE | ID: mdl-36243307

RESUMO

Nanomedicine has revolutionized the available treatment options during the last decade, but poor selectivity of targeted drug delivery and release is still poses a challenge. In this study, doxorubicin (DOX) and magnetite nanoparticles were encapsulated by freezing-induced loading, coated with polymeric shell bearing two bi-layers of polyarginine/dextran sulphate and finally modified with HER2-specific DARPin proteins. We demonstrated that the enhanced cellular uptake of these nanocarriers predominantly occurs by SKOV-3 (HER2+) cells, in comparison to CHO (HER2-) cells, together with the controlled DOX release using low intensity focused ultrasound (LIFU). In addition, a good ability of DARPin+ capsules to accumulate in the tumor and the possibility of combination therapy with LIFU were demonstrated. A relatively high sensitivity of the obtained nanocarriers to LIFU and their preferential interactions with mitochondria in cancer cells make these carriers promising candidates for cancer treatment, including novel approaches to overcome drug resistance.


Assuntos
Óxido Ferroso-Férrico , Polímeros , Nanomedicina , Doxorrubicina/farmacologia
2.
Biochemistry (Mosc) ; 81(7): 709-22, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-27449617

RESUMO

In this review we discuss features of mRNA synthesis and modifications used to minimize immune response and prolong efficiency of the translation process in vivo. Considerable attention is given to the use of liposomes and nanoparticles containing lipids and polymers for the mRNA delivery. Finally we briefly discuss mRNAs which are currently in the clinical trials for cancer immunotherapy, vaccination against infectious diseases, and replacement therapy.


Assuntos
Portadores de Fármacos/química , RNA Mensageiro/metabolismo , Animais , Humanos , Imunidade Inata , Imunoterapia , Lipossomos/química , Nanopartículas/química , Neoplasias/imunologia , Neoplasias/terapia , RNA Mensageiro/química , RNA Mensageiro/genética , Vacinação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA